A detailed history of Fil LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Fil LTD holds 51,938 shares of RPRX stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,938
Previous 46,619 11.41%
Holding current value
$1.33 Million
Previous $1.23 Million 19.53%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$25.63 - $29.27 $136,325 - $155,687
5,319 Added 11.41%
51,938 $1.47 Million
Q2 2024

Aug 13, 2024

BUY
$26.26 - $29.9 $620,733 - $706,776
23,638 Added 102.86%
46,619 $1.23 Million
Q1 2024

May 13, 2024

BUY
$27.46 - $31.33 $44,512 - $50,785
1,621 Added 7.59%
22,981 $697,000
Q4 2023

Feb 13, 2024

BUY
$26.21 - $29.22 $41,909 - $46,722
1,599 Added 8.09%
21,360 $600,000
Q3 2023

Nov 13, 2023

BUY
$26.26 - $31.38 $47,688 - $56,986
1,816 Added 10.12%
19,761 $536,000
Q2 2023

Aug 11, 2023

SELL
$29.6 - $36.56 $40,285 - $49,758
-1,361 Reduced 7.05%
17,945 $551,000
Q1 2023

May 11, 2023

BUY
$32.77 - $39.4 $373,774 - $449,396
11,406 Added 144.38%
19,306 $695,000
Q4 2022

Feb 13, 2023

BUY
$39.17 - $44.04 $309,443 - $347,916
7,900 New
7,900 $312,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.